Halozyme, Roche deal

The companies partnered to use HTI's Enhanze recombinant human hyaluronidase

Read the full 106 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE